When “Real Housewives of New Jersey” cast member Dolores Catania said she was taking Ozempic ahead of filming the reunion episodes for the show’s 13th season, the tweets followed.
On the Tuesday, April 4, episode of “Watch What Happens Live,” host Andy Cohen commented that the reality star, 52, was “looking thin” and asked if she was taking Ozempic, a medication that’s been approved by the U.S. Food and Drug Administration to treat Type 2 diabetes and can also induce weight loss. She said yes, though she later revealed she’s taking Mounjaro, another Type 2 diabetes drug that can induce weight loss, according to manufacturer Eli Lilly.
Catania hasn’t shared whether she has medical reasons for taking Mounjaro.
Cohen joked, “What housewife isn’t on Ozempic?” referring to the universe of women in Bravo’s Real Housewives franchise. Catania replied that she wasn’t going to show up to reunion “looking any bigger than any than anyone else.”
“So I got on the bandwagon,” the mother of two added. Asked if she has any side effects, she said that she just feels “not hungry.”
At least two other women on “Real Housewives of New Jersey” have also said they’re taking medication for weight loss. Margaret Josephs told Insider, and Jennifer Fessler shared on “Watch What Happens Live.”
Both semaglutide and tirzepatide, the generic names for Ozempic and Mounjaro respectively, work by activating receptors in the brain that in turn stimulate nerves that mimic the effect of eating, TODAY.com and NBC News previously reported.
After Catania publicly shared the reason for her recent weight loss, social media users were quick to react.
“Wait isn’t there a shortage of ozempic for diabetes patients? And Dolores just casually admitted she’s on it with a big smile on her face?” one person tweeted. (The FDA lists both semaglutide and tirzepatide injections as currently in a shortage.)
“Dolores admits to being on…
Read the full article here
